Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf
75N98026Q01067 · HEALTH AND HUMAN SERVICES, DEPARTMENT OF
A MEDICAL LABORATORIES solicitation, with responses due 2026-09-04. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension
Comparable recent awards in MEDICAL LABORATORIES
| Winner | Award value | Offers | Date |
|---|---|---|---|
| TESTUDO LOGISTICS LLC | $269K | n/a | 2026-07-02 |
| TESTUDO LOGISTICS LLC | $269K | 1 | 2026-07-02 |
| UNIVERSITY OF COLORADO HOSPITAL AUTHORITY | $381K | n/a | 2026-06-30 |
| QUEST DIAGNOSTICS INCORPORATED | $4.1M | 1 | 2026-06-30 |
| MEMORIAL HOSPITAL OF LARAMIE COUNTY | $200K | 1 | 2026-06-30 |
Questions
What is solicitation 75N98026Q01067?
Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf, issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF, under NAICS 621511 (MEDICAL LABORATORIES). Responses are due 2026-09-04.
What do similar contracts close for?
Comparable closed awards in this category ran from $200K to $4.1M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.